Related Experiment Videos
Gene therapy for hemophilia: a step closer to reality
1Division of Hematology-Oncology, University of North Carolina School of Medicine, Chapel Hill 27599-7035, USA. gcwhite@med.unc.edu
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immune tolerance induction: What have we learned over time?
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Progressive improvement in wound healing with increased therapy in haemophilia B mice.
Haemophilia : the official journal of the World Federation of Hemophilia·2013
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation.
Journal of thrombosis and haemostasis : JTH·2009
Breeding in high-elevation habitat results in shift to slower life-history strategy within a single species.
The Journal of animal ecology·2008
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia·2008
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B.
Journal of thrombosis and haemostasis : JTH·2007
Discovery of synthetic TBK1 activator inducing type I interferon mediated antiviral and antitumor immunity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Healing helminths: The disease-modifying potential of helminth-derived proteins in animal models of inflammatory disease - a systematic review.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
C-terminus CD28 phosphorylation, Y218, modulates IL-2 secretion and therapeutic effect of CAR-T cells.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Targeting EZH2 and EGFR Therapeutic Vulnerabilities of TNBC with a Single Chemical Entity Confers Preclinical Treatment Advantage.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
ACC1 inhibition enhances BCG-induced trained immunity by reprogramming Acetyl-CoA metabolism.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.
Journal of the American College of Cardiology·2026
Advanced therapy medicinal products in Saudi Arabia: Regulation and development.
Regenerative therapy·2026
ADHERENCE PATTERNS AND THEIR DETERMINANTS TO CFTR MODULATORS IN FRANCE.
Respiratory medicine·2026